A Study of MIRCERA in Participants With Chronic Kidney Disease Stage 3-4 and Not on Dialysis
NCT ID: NCT02567188
Last Updated: 2025-09-11
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
144 participants
OBSERVATIONAL
2009-04-30
2011-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Observational Study of Mircera in Patients With Chronic Renal Anemia on Dialysis (CKD Stage V) or Not on Dialysis (CKD Stage III-IV)
NCT01667380
An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) as Maintenance Treatment in Patients With Chronic Renal Anemia on Haemodialysis
NCT01422824
A Study of MIRCERA for the Intrapetient Variability of Hemoglobin Levels in Patients With Chronic Renal Anemia (RIVAL)
NCT01356589
A Study Of Mircera In Patients With Kidney Disease Who Are Not On Dialysis
NCT02490514
An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease in Pre-Dialysis or Dialysis
NCT01309295
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort of CKD Participants
Pre-dialysis participants with CKD treated with MIRCERA according to the current standard of care and in line with the current local summary of product characteristics were observed for maximum of 12 months.
MIRCERA
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MIRCERA
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pre-dialysis participants with CKD stage 3-4 treated with MIRCERA and continue in the pre-dialysis state for the whole study period
* Estimated glomerular filteration rate (e-GFR) between 15-60 milliliter per minute (mL/min) (calculated)
Exclusion Criteria
* Participants with life expectancy less than 1 year
* Active malignancy
* Planned living kidney transplant within 6 months.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hoffmann-La Roche
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trials
Role: STUDY_DIRECTOR
Hoffmann-La Roche
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Angeholm, , Sweden
Bollnäs, , Sweden
Eskilstuna, , Sweden
Gävle, , Sweden
Gothenburg, , Sweden
Gothenburg, , Sweden
Huddinge, , Sweden
Jönköping, , Sweden
Karlshamn, , Sweden
Karlstad, , Sweden
Kristianstad, , Sweden
Linköping, , Sweden
Mölndal, , Sweden
Norrköping, , Sweden
Skövde, , Sweden
Stockholm, , Sweden
Stockholm, , Sweden
Umeå, , Sweden
Värnamo, , Sweden
Västervik, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ML22439
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.